awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43848133-4A46F842-FD45-4858-B2A5-542A4ABE7A37
Q43848133-4A46F842-FD45-4858-B2A5-542A4ABE7A37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43848133-4A46F842-FD45-4858-B2A5-542A4ABE7A37
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.
P2860
Q43848133-4A46F842-FD45-4858-B2A5-542A4ABE7A37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43848133-4A46F842-FD45-4858-B2A5-542A4ABE7A37
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
14164f50b55879da001ea4039327d699db5101d0
P2860
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.